MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,774 | -61.4% | 30,649 | +0.1% | 0.00% | – |
| Q2 2023 | $100,576 | -20.3% | 30,616 | -0.1% | 0.00% | – |
| Q1 2023 | $126,147 | +89.7% | 30,656 | +170.3% | 0.00% | – |
| Q4 2022 | $66,512 | -13.7% | 11,341 | -50.0% | 0.00% | – |
| Q3 2022 | $77,077 | +45.4% | 22,684 | +100.0% | 0.00% | – |
| Q2 2022 | $53,000 | +17.8% | 11,343 | +1.3% | 0.00% | – |
| Q1 2022 | $45,000 | -35.7% | 11,198 | -0.1% | 0.00% | – |
| Q4 2021 | $70,000 | -99.7% | 11,207 | -98.8% | 0.00% | -100.0% |
| Q4 2020 | $24,455,000 | +44.5% | 919,101 | +1.1% | 0.01% | +22.2% |
| Q3 2020 | $16,922,000 | +1162.8% | 908,845 | +1484.3% | 0.01% | +800.0% |
| Q2 2020 | $1,340,000 | – | 57,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |